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Taurocholate 
A B S T R A C T   
The interplay between diet, intestinal microbiota and host is a major factor impacting health. A diet rich in 
unsaturated fatty acids has been reported to stimulate the growth of Bilophila wadsworthia by increasing the 
proportion of the sulfonated bile acid taurocholate (TC). The taurine-induced overgrowth of B. wadsworthia 
promoted the development of colitis in interleukin-10-deficient (IL-10-/-) mice. This study aimed to investigate 
whether intake of the sulfonates sulfoquinovosyl diacylglycerols (SQDG) with a dietary supplement or their 
degradation product sulfoquinovose (SQ), stimulate the growth of B. wadsworthia in a similar manner and, 
thereby, cause intestinal inflammation. Conventional IL-10-/- mice were fed a diet supplemented with the SQDG- 
rich cyanobacterium Arthrospira platensis (Spirulina). SQ or TC were orally applied to conventional IL-10-/- mice 
and gnotobiotic IL-10-/- mice harboring a simplified human intestinal microbiota with or without B. wadsworthia. 
Analyses of inflammatory parameters revealed that none of the sulfonates induced severe colitis, but both, 
Spirulina and TC, induced expression of pro-inflammatory cytokines in cecal mucosa. Cell numbers of 
B. wadsworthia decreased almost two orders of magnitude by Spirulina feeding but slightly increased in gnoto-
biotic SQ and conventional TC mice. Changes in microbiota composition were observed in feces as a result of 
Spirulina or TC feeding in conventional mice. In conclusion, the dietary sulfonates SQDG and their metabolite SQ 
did not elicit bacteria-induced intestinal inflammation in IL-10-/- mice and, thus, do not promote colitis.   
1. Introduction 
The incidence of inflammatory bowel diseases (IBD) is rising 
worldwide (Ng et al., 2017). Risk factors include genetic predisposition, 
a Westernized lifestyle and a detrimental bacterial composition in the 
gut (Chiba et al., 2019; Piovani et al., 2019). To mimic the genetic 
predisposition for IBD, different animal models of colitis have been 
generated over the years (Kiesler et al., 2015). The 
interleukin-10-deficient (IL-10-/-) mouse model develops spontaneous 
chronic colitis under specific pathogen-free (SPF) conditions, which is 
mediated by a lack of anti-inflammatory IL-10 (Kühn et al., 1993; 
Shouval et al., 2014). Since germ-free IL-10-/- mice do not develop co-
litis, intestinal bacteria were identified as a pivotal factor in disease 
development (Sellon et al., 1998). The microbial community in the gut, 
referred to as intestinal microbiota, can be influenced favorably or 
adversely by the diet ingested by the host (David et al., 2014). For 
example, it has been shown that a diet rich in fiber increases the 
abundance of bacteria that produce short chain fatty acids in the colon, 
which promotes host health (Bishehsari et al., 2018). Conversely, a diet 
rich in saturated fatty acids fed to mice shifted the bile composition 
towards a greater proportion of taurocholate (TC) and, thereby, stimu-
lated the growth of the sulfite-reducing pathobiont Bilophila 
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wadsworthia. The overgrowth of B. wadsworthia was accompanied by an 
increased incidence and severity of colitis in IL-10-/- mice. This colito-
genic effect was even more pronounced when the sulfonate TC was 
orally applied to IL-10-/- mice fed a low-fat diet (Devkota et al., 2012) 
(Fig. 1). Based on these findings, the question arose whether sulfonates 
ingested with diet may also stimulate the growth of B. wadsworthia and, 
thus, promote intestinal inflammation in a susceptible host. 
Widespread sulfonates in nature are sulfolipids present in photo-
synthetic organisms. Dietary sources rich in sulfolipids are green leafy 
vegetables and cyanobacteria, some of which are used as functional 
supplements. Main representatives of sulfolipids in such sources are 
sulfoquinovosyl diacylglycerols (SQDG, structure in Fig. 1). Consump-
tion of high amounts of green vegetables or cyanobacteria such as 
Arthrospira platensis (commercially known as Spirulina) as dietary sup-
plements may increase the availability of sulfonates in the intestinal 
tract of humans. The sulfoquinovosidase cleaves SQDG to release the 
sulfonated glucose derivative sulfoquinovose (SQ, structure in Fig. 1). 
The enzyme was identified in Escherichia coli K-12 and characterized 
(Denger et al., 2014; Speciale et al., 2016). Moreover, E. coli K-12 was 
shown to degrade SQ via sulfofructose-1-phosphate to 2,3-dihydroxy-
propane-1-sulfonate (DHPS, structure in Fig. 1) and dihydroxyacetone 
phosphate by the sulfo-Embden-Meyerhof-Parnas (sulfo-EMP) pathway 
(Denger et al., 2014). The corresponding gene cluster was identified in 
E. coli K-12 MG1655 but is also present in many other E. coli strains and a 
wide range of Enterobacteriaceae (Denger et al., 2014; Li et al., 2020). A 
second sulfoglycolytic pathway was first described in Pseudomonas 
putida SQ1 and seems to be active in other respiring α-, β- and γ-pro-
teobacteria (Felux et al., 2015). This sulfo-Entner-Doudoroff (sulfo-ED) 
pathway degrades SQ via 6-deoxy-6-sulfogluconate to sulfolactate and 
pyruvate. A third pathway for SQ degradation involving a novel 6-deox-
y-6-sulfofructose transaldolase and resulting in formation of 
fructose-6-phosphate and sulfolactate has recently been reported in 
Bacillus strains (Frommeyer et al., 2020; Liu et al., 2020a). Corre-
sponding gene clusters of this transaldolase pathway were identified in a 
number of environmental and intestinal Firmicutes species. However, 
strictly anaerobic clostridia among those bacteria seem to produce DHPS 
instead of sulfolactate by employing a sulfolactaldehyde reductase 
similar to that found in the sulfo-EMP pathway (Frommeyer et al., 
2020). Thus, it is conceivable that DHPS formed from SQ by intestinal 
E. coli or Firmicutes strains is released into the intestinal lumen, where it 
may serve as a sulfite source for B. wadsworthia or other sulfite-reducing 
bacteria, similar to taurine. While utilization of taurine by 
B. wadsworthia has been known for a long time (Laue et al., 1997), 
degradation of DHPS by this bacterium and the enzymes involved have 
been reported only recently (Liu et al., 2020b). Sulfonate-dependent 
stimulation of growth of these sulfite-reducing bacteria may promote 
intestinal inflammation, either owing to their cell-based immune-acti-
vating properties or the increased production of hydrogen sulfide (H2S) 
in the colon (Fig. 1). The role of H2S has been discussed controversially, 
ranging from health-promoting (Faller et al., 2018) to toxic (Leschelle 
et al., 2005) effects. Recent studies argue in favor of a 
concentration-dependent mode of action of H2S with beneficial effects at 
physiological doses and detrimental consequences evoked by high 
concentrations (Beaumont et al., 2016). B. wadsworthia has been linked 
to various types of inflammation since its discovery by Baron et al. in 
1989, as it was isolated from appendicitis, abscesses and other inflamed 
tissues (Baron et al., 1989; Finegold et al., 1992). The potential of 
B. wadsworthia to induce a T helper 1 (Th1) cell-mediated inflammatory 
response, metabolic dysfunctions and even systemic inflammation in its 
host has been described earlier (Devkota et al., 2012; Feng et al., 2017; 
Natividad et al., 2018), but the underlying mechanisms have not been 
elucidated. 
Evaluation of the impact of specific diets or dietary components on 
gut microbiota composition is challenging, because of this ecosystem’s 
complexity, inter-individual differences and changes over time. There-
fore, minimal consortia of representative gut bacterial species have been 
used as standardized models for mechanistic studies (Basic and Bleich, 
2019). We previously established a simplified human intestinal micro-
biota (SIHUMI) in rodents that mimics metabolic key functions of the 
human gut microbiota (Becker et al., 2011). The SIHUMI consortium 
consists of eight bacterial species, which are prominent members of the 
human intestinal microbiota and are stably transferred from one gen-
eration of mice to another. This minimal consortium may be further 
expanded by additional bacterial species to assess their functional role in 
a more complex but defined intestinal setting. 
In the present study, we investigated the effects of diet-derived sul-
fonates, SQDG, and their degradation product SQ on gut microbiota 
composition and consequences for the host health. Therefore, we fed 
conventional IL-10-/- mice an SQDG-rich Spirulina diet and orally 
treated both conventional and gnotobiotic IL-10-/- mice with SQ. Sub-
sequent analyses focused on the assessment of intestinal inflammation 
and abundance of B. wadsworthia. 
2. Materials and methods 
2.1. Bacterial growth conditions 
Bilophila wadsworthia DSM 11045 was purchased from the German 
Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, 
Germany). B. wadsworthia was grown under anoxic conditions at 37 ◦C 
in a liquid culture medium adapted from da Silva et al. (da Silva et al., 
2008) (DS medium), which contained 19 mM NH4Cl, 17 mM NaCl, 2 mM 
MgCl2, 7 mM KCl, 0.3 mM CaCl2, 1 mM K2HPO4, 40 mM sodium 
DL-lactate, 40 mM sodium formate, yeast extract (3.5 mg/L), 
selenite-tungstate solution (1 mL/L, see DSMZ medium 385, www.dsmz. 
de), trace element solution (1 mL/L, see DSMZ medium 320), 1,4-naph-
thoquinone (200 μg/L) and 2 μM resazurin. The medium was adjusted to 
pH 7.4, gas flashed with N2/CO2 (80/20, v/v) and autoclaved in 
gas-tight Hungate tubes. Directly before use, Ti(III) nitrilotriacetate (20 
mL/L, Moench and Zeikus, 1983), seven-vitamin solution (1 mL/L, see 
Fig. 1. Conversion of sulfonates by gut bacteria and potentially associated 
colitogenic effects. R1 and R2 indicate fatty acids. Dsr, dissimilatory sul-
fite reductase. 
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DSMZ medium 503), 30 mM NaHCO3 and 20 mM taurine were sterile 
filtered and added to the medium. Members of the SIHUMI consortium 
from the strain collection of the German Institute of Human Nutrition 
Potsdam-Rehbruecke (DIfE) were cultivated anoxically in Brain Heart 
Infusion (BHI) broth (Roth), supplemented with yeast extract (5 g/l, 
Roth) and 5 hemin (mg/l, Serva) (YH-BHI medium). To grow Clostridium 
ramosum, YH-BHI medium was mixed in equal parts with Yeast Casitone 
Fatty Acid (YCFA) medium (DSMZ medium 1611). 
2.2. Fecal incubation experiments 
Fresh fecal samples from four IL-10-/- mice each were collected, 
transferred into an anaerobic workstation (M85, Don Whitley Scientific, 
Shipley, UK) and individually 10-fold diluted (w/v) in DS medium 
without taurine. Following low-speed centrifugation (300 x g, 4 ◦C, 5 
min), 1 mL fecal suspension was injected into a Hungate tube containing 
9 mL DS medium supplemented with 4 mM SQ (MCAT, Donaueschingen, 
Germany), 20 mM sodium TC (Roth) or without sulfonates. Incubations 
of SQ and TC in the absence of fecal suspensions were included as 
controls. All incubations were performed in duplicates. The tubes were 
incubated at 37 ◦C for 168 h. Samples (250 μL) were withdrawn for 
sulfide quantification using the methylene blue method (Strocchi et al., 
1992) at 0 h and 168 h and immediately transferred into reaction tubes 
containing 25 μL 327 mM ZnAc and 5 μL 100 mM NaOH. To these 
mixtures, 20 μL detection reagent (per liter, 3.45 g N,N-dimethyl-1, 
4-phenylenediamine x 2 HCl, 6 g Fe (III)-chloride x 6 H2O dissolved in 
18.5 % HCl) was added, incubated for 20 min and centrifuged (12 000 x 
g, 23 ◦C, 3 min). Supernatants were transferred to 96-well plates and 
analyzed at 670 nm (Infinite M200 PRO, Tecan). Sulfide concentrations 
were calculated based on a calibration curve prepared from Na2S solu-
tions (40–200 mM) treated in the same way as the samples. If necessary, 
samples were diluted with distilled water. 
2.3. Animal experiments 
Animal experiments were approved by the State Office for Occupa-
tional Safety, Consumer Protection and Health of the State of Bran-
denburg, Germany (approval number: 2347− 10-2016). The 
experiments were conducted with 10- to 12-week-old conventional and 
gnotobiotic C57BL/6.129P2-Il10tm1Cgn (IL-10-/-) mice. The IL-10 gene 
disruption was confirmed for each mouse by genotyping using DNA 
extracts of the tail tip and performing specific PCR runs targeting wild 
type and mutant gene variants. Conventional male mice were bred 
under SPF conditions in the animal facility of the DIfE. Mice were 
housed in individually ventilated cages and kept in a 12 h light-dark 
cycle at 22 ± 2 ◦C and 55 ± 5% air humidity. Feed (Ssniff standard 
chow A153 F0300 Am R/M− H; Ssniff, Soest, Germany) and water were 
applied ad libitum. 
Male and female gnotobiotic mice harbored the SIHUMI consortium 
from birth on. This community consists of eight bacterial species: 
Anaerostipes caccae DSM 14662T, Bacteroides thetaiotaomicron DSM 
2079T, Bifidobacterium longum NCC 2705, Blautia producta DSM 2950T, 
Clostridium butyricum DSM 10702T, Clostridium ramosum DSM 1402T, 
Escherichia coli K-12 MG1655 and Lactobacillus plantarum DSM 20174T. 
Mice were kept under the same environmental conditions as the con-
ventional animals but in sterile positive-pressure isolators (Metall & 
Plastik, Radolfzell, Germany). Wood chips and feed (Altromin fortified 
type 1310; Altromin, Lage, Germany) were irradiated with 50 kGy 
(Synergy Health Radeberg, Radeberg, Germany). Drinking water was 
autoclaved twice and applied ad libitum. 
For the feeding experiments, 24 conventional mice were adapted to 
an irradiated semisynthetic diet (control diet, Supplementary Table 1) 
for two weeks. Subsequently, 12 mice were switched to an irradiated 
diet containing 20 % Spirulina powder (Spirulina diet, Supplementary 
Table 1). The remaining 12 mice kept on consuming the control diet. The 
two diets were prepared to contain comparable amounts of 
macronutrients and minerals by considering their levels present in the 
Spirulina supplement (Supplementary Table 1). The similar caloric 
content of CD and SD was subsequently confirmed by bomb calorimetry 
(C5003 calorimeter, IKA, Staufen, Germany). 
For experiments involving conventional mice gavaged with pure 
compounds, 34 animals were fed the control diet and allocated to three 
groups. Following a two-week adaptation phase, mice were orally gav-
aged with equimolar doses of SQ (0.45 g/kg body weight, n = 12) or 
sodium TC (1 g/kg body weight, n = 10) or with water as vehicle control 
(n = 12). SQ and water were applied daily, whereas TC was given twice 
per week to avoid toxic effects. 
For experiments with gnotobiotic mice and pure compounds, 48 
SIHUMI mice were adapted to the control diet for two weeks. Thereafter, 
24 SIHUMI mice were transferred to a separate isolator and additionally 
colonized with B. wadsworthia by orally gavaging 108 cells in 150–200 μl 
culture medium. Sterile medium was orally applied to the remaining 24 
mice. The successful colonization with B. wadsworthia was confirmed 
one day after inoculation by qPCR with DNA extracted from fecal 
samples. Cell numbers ranged between 9.4 and 9.9 log/g feces. Both the 
SIHUMI and SIHUMI + B. wadsworthia (SIHUMI + Bw) groups were 
divided into three subgroups that were orally gavaged with SQ (0.45 g/ 
kg body weight, n = 8), sodium TC (1 g/kg body weight, n = 8) or water 
(n = 8) twice per week. 
Body weight and feed intake were recorded twice per week. Fresh 
fecal samples were collected before start of intervention (0 d) and after 
18 days of intervention (18 d) and stored at – 20 ◦C until being processed 
for 16S rRNA gene sequencing (see below). At day 14 of the interven-
tion, a colon permeability test (see below) was performed. After three 
weeks of intervention, mice were euthanized with isoflurane and blood 
was withdrawn by cardiac puncture into sterile EDTA-coated monov-
ettes (Sarstedt). The tip of the cecum including its content was fixed in 
Carnoy’s solution and embedded in paraffin for later histological 
assessment. Contents of the remaining part of the cecum were collected 
and the mucosa scraped. Mucosa samples were snap-frozen in liquid 
nitrogen and stored at - 80 ◦C. Intestinal contents were kept on ice until 
storage at - 20 ◦C. Blood was centrifuged (2 000 x g, 4 ◦C, 10 min), and 
the plasma stored at - 80 ◦C. 
2.4. Colon permeability test 
Colonic permeability was assessed with the fluorescein isothiocya-
nate (FITC)-dextran assay (Volynets et al., 2016) after two weeks of 
intervention. Briefly, mice were fasted for three hours and subsequently 
received an oral dose of 4 kDa FITC-dextran (600 mg/kg body weight, 
Sigma) in phosphate-buffered saline (PBS) or PBS for blank measure-
ments. Four hours later, blood samples were withdrawn from the ret-
robulbar capillary plexus into heparinized microvettes (Sarstedt). 
Plasma was gained after centrifugation (2 000 x g, 4 ◦C, 5 min). The 
fluorescence measurements were performed as described previously 
(Woting and Blaut, 2018). Mean fluorescent values of mice receiving 
PBS were subtracted from those determined for FITC-dextran-treated 
mice. 
2.5. Histopathological assessment 
Slices of paraffin-embedded cecal and colonic tissues were cut, 
stained with hematoxylin and eosin and examined in a standardized and 
blinded fashion. The histopathology score included evaluation of the 
lumen, surface epithelium, lamina propria and submucosa and reached 
from zero (no inflammation in any region) to 28 (severe inflammation in 
all four regions) (Ring et al., 2019). 
2.6. Gene expression analysis 
Total RNA was extracted from cecal and colonic mucosa samples 
using the peqGOLD TriFast™ reagent (Peqlab, Erlangen, Germany) 
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according to the manufacturer’s instructions. Genomic DNA was 
degraded by treatment with DNAse I (Thermo Fisher Scientific), and its 
removal controlled by qPCR using the TaqMan Universal PCR master 
mix (Thermo Fisher Scientific) with primers (Eurofins Genomics) tar-
geting the 18S rRNA gene (Katterle et al., 2008). RNA integrity was 
assessed by performing a denaturing gel electrophoresis in the presence 
of ethidium bromide. Subsequent synthesis of complementary DNA 
(cDNA) was done using 1 μg of RNA and the RevertAid H Minus First 
Strand cDNA Synthesis kit (Thermo Fisher Scientific). Each qPCR reac-
tion mix contained 2.5 μL Power SYBR Green master mix (Thermo Fisher 
Scientific), 0.5 μL each forward and reverse primer (3 μM each, Sup-
plementary Table 2; Eurofins Genomics), 0.5 μL diethyl pyrocarbonate 
(DEPC)-treated water and 1 μL cDNA solution corresponding to 5 ng of 
original RNA. The Viia™ 7–Real-Time PCR System (Applied Biosystems) 
was employed with the QuantStudio Real-Time PCR System software 
version 1.3 (Thermo Fisher Scientific). Thermal cycling conditions of the 
qPCR reactions were: polymerase activation at 94 ◦C for 4 min, 40 cycles 
of denaturation at 94 ◦C for 15 s and annealing/elongation at 60 ◦C for 
30 s. Specificity of the amplification was confirmed by melting curve 
analysis. Gene expression levels were calculated by the ΔΔCT method 
(Pfaffl, 2001) with the gene encoding hypoxanthine guanine phos-
phoribosyl transferase (Hprt) as the housekeeping gene and relative to 
the respective control group normalized to the value one. 
2.7. Cytokine analysis 
Enzyme-linked immunosorbent assays (ELISA) were performed with 
mouse-specific kits quantifying tumor necrosis factor (TNF)-α 
(BMS607− 3), interferon (IFN)-γ (KMC4021), serum amyloid (SA) A 
(KMA0021) (all from Thermo Fisher Scientific) or lipocalin (LCN) 2 
(MLCN20; R & D Systems, Minneapolis, MN, USA) in plasma samples. 
Procedures and quantification were performed in accordance with the 
manufacturer’s instructions. 
2.8. Quantification of bacterial cells 
DNA was extracted from cecal and colonic contents and fecal samples 
using the PSP Spin Stool DNA kit (Invitek, Berlin, Germany) by following 
the manufacturer’s instructions. For each qPCR reaction, 2.5 μL Quan-
tiNova SYBR Green PCR master mix, 0.025 μL ROX reference dye (both 
from Qiagen, Hilden, Germany), 0.5 μL each forward and reverse primer 
(3 μM each, Supplementary Table 3; Eurofins Genomics) and 0.475 μL 
water were combined with 1 μL extracted DNA. The thermal conditions 
for the qPCR reactions were as described for the gene expression anal-
ysis, with individual adjustments for the annealing and elongation 
temperature (Supplementary Table 3). Reactions were run using the 
same real-time PCR system as described above for gene expression 
analysis. Bacterial counts were determined according to standard curves 
based on samples with known cell numbers. Therefore, cells in fresh 
liquid cultures were counted microscopically using a Thoma counting 
chamber. Volumes containing 108 (for B. wadsworthia) or 109 (for 
SIHUMI bacteria) cells were pelleted (14 000 x g, 4 ◦C, 5 min). Sterile 
feces from germ-free mice were spiked with the cell pellet, and DNA was 
extracted as described above. Serial dilutions ranging from 109 or 108 to 
103 cells were prepared and included in each qPCR run. All samples and 
standards were analyzed in triplicates. Specificity of amplification was 
tested by melting curve analysis, and samples showing unspecific 
amplification were excluded. Cell numbers were calculated per sample 
wet weight. As low cell numbers of L. plantarum were not detectable by 
qPCR, the presence of this bacterium was verified by plating fecal sus-
pensions on Rogosa agar (Oxoid). 
2.9. Analysis of microbiota composition 
DNA was extracted from cecal content and feces followed by 
sequencing of the V3 and V4 regions of the 16S rRNA gene (ZIEL Core 
Facility Microbiome/NGS, Technical University Munich, Germany) 
using the Illumina technology described previously (Lagkouvardos 
et al., 2015). Sequences were further processed using the Integrated 
Microbial Next Generation Sequencing (IMNGS) platform (Lagkou-
vardos et al., 2016) and the Rhea software (Lagkouvardos et al., 2017). 
Non-metric Multidimensional Scaling (NMDS) plots visualize 
β-diversity. 
2.10. Statistical analyses 
The distribution of data was tested for normality using the 
Kolmogorov-Smirnov test. If a data set passed the normality test, it is 
presented as mean ± SEM and analyzed for differences using the Stu-
dent’s t-test. If not, the data set is shown as median ± 95 % CI and the 
Mann-Whitney U test was applied. Outliers were identified using the 
ROUT method (Q = 0.1 %) and excluded. Sets of data were considered 
significantly different at *P < 0.05, **P < 0.01, ***P < 0.001 and ****P 
< 0.0001. The software used for statistical analysis and visualization 
was Graph Pad Prism 8.2.1 (GraphPad Software, La Jolla, CA, USA). For 
analysis of β-diversity of 16S rRNA gene sequencing data, generalized 
UniFrac was applied with P values from the PERMANOVA test, and the 
Bonferroni-Hochberg test was used to correct for multiple testing. 
3. Results 
3.1. Intestinal microbiota of conventional mice converted SQ and TC to 
sulfide 
Whether the intestinal microbiota of conventional IL-10-/- mice is 
capable of liberating sulfide from SQ or TC was investigated by incu-
bating fecal suspensions individually with either sulfonate under anoxic 
conditions for 168 h. The fecal microbiotas of all four donor mice 
catalyzed the formation of sulfide from both SQ and TC. The mean 
estimated concentrations of sulfide formed from SQ and TC in fecal in-
cubations were 6.6 ± 0.6 mM and 5.2 ± 1.6 mM, respectively (Sup-
plementary Fig. 1). No sulfide was observed in fecal incubations without 
sulfonates or vice versa. 
3.2. Spirulina feeding modulated immune-related factors and bacterial 
abundance 
To investigate whether SQDG stimulates the growth of colitogenic 
B. wadsworthia, conventional IL-10-/- mice were fed a diet supplemented 
with 20 % Spirulina (SD), which is particularly rich in SQDG compared 
to other sources, or an isocaloric control diet (CD) for 3 weeks. Within 
the first three days, body weight gain and feed consumption of SD-fed 
mice were increased compared to CD-fed mice (Fig. 2A, B). There-
after, the body weight of the SD group remained at an elevated level 
until day 18, but did not differ significantly from the body weight of the 
CD group at the end of the experiment on day 21 (Fig. 2A). From day 
seven on until the end of the intervention phase, the feed consumption of 
SD-fed mice decreased to amounts similar to those observed for CD-fed 
mice (Fig. 2B). Histopathological scores of cecal tissue obtained after 21 
d of intervention were slightly elevated in SD-fed mice (mean score 2.9 
± 0.4) compared to CD-fed mice (mean score 0.8 ± 0.5) (Fig. 2C). The 
increased histopathology score was mainly due to mild to moderate 
immune-cell infiltration into the lamina propria of the cecum. In addi-
tion, expression of Tnf-α in the cecal mucosa of SD-fed animals was 2.4- 
fold increased, while gene expression of other cytokines did not differ 
between the SD and CD groups (Fig. 2D). Systemic inflammation was not 
observed as plasma concentrations of the inflammatory markers TNF-α, 
IFN-γ, SAA, and LCN 2 were not significantly increased in the SD 
compared to the CD group (Fig. 2E). Colon permeability was not affected 
by Spirulina feeding as determined with the FITC-dextran assay 
(Fig. 2F). 
Fecal cell numbers of B. wadsworthia determined before diet change 
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were approximately 8 log/g and did not differ between SD and CD mice 
(Supplementary Fig. 2A). No difference in microbiota composition was 
observed between the groups at baseline (Supplementary Fig. 3A). After 
21 d of intervention, the cell number of B. wadsworthia was significantly 
decreased by 1.9 log/g in cecal contents of SD-fed compared to CD-fed 
mice (Fig. 3A). Overall, a difference in β-diversity of cecal microbiota 
between SD and CD mice was observed (Fig. 3B), but none in α-diversity 
(data not shown). The microbiota composition determined in feces of SD 
and CD mice after 18 d of the study differed accordingly (P = 0.018) 
(Supplementary Fig. 3B). Microbiota changes occurred in the course of 
0 d to 18 d in the SD mice (P = 0.008) (Supplementary Fig. 3C). Such 
changes were not observed in CD mice (Supplementary Fig. 3D). After 
18 d, Porphyromonadaceae were more abundant in feces of the mice fed 
SD compared to the mice fed CD (31.4 versus 12.6 %, P = 0.008). The 
Fig. 2. Inflammation-associated parameters in conventional IL-10-/- mice fed Spirulina diet (SD) or control diet (CD). (A) Body weight development relative to the 
first day of intervention. Dashed line at 0 % body weight change (mean ± SEM, **P < 0.01, ***P < 0.001, n = 12 per group). (B) Diet consumed per mouse and day 
(mean ± SEM, ***P < 0.001, n = 12 per group). (C) Histopathological scoring of cecal tissue (mean ± SEM, ***P < 0.001, n = 12 per group). Straight line indicates 
the maximal score of 28. (D) Gene expression analysis of cytokines in cecal mucosa (median + 95 % CI, *P < 0.05, n = 12 per group). (E) Plasma concentrations of 
inflammatory markers (mean ± SEM, n = 3 – 4 per group). (F) FITC-dextran concentrations in plasma following the colon permeability test conducted after two 
weeks of intervention (mean ± SEM, n = 8 per FITC-dextran group, n = 4 per PBS group). Ifn-γ, interferon γ; Il, interleukin; LCN 2, lipocalin 2; SAA, serum amyloid A; 
Tnf-α, tumor necrosis factor α; n.d. = not detected. 
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same applied to cecal content after 21 d (27.4 versus 15.9 %, P = 0.008) 
of intervention. After 21 d, the relative abundance of members of 
Desulfovibrionaceae in cecal content was lower in SD mice than in CD 
mice (3.1 versus 1.5 %, P = 0.008). These data correspond to lower cecal 
B. wadsworthia counts in SD mice compared to CD mice detected by 
qPCR (Fig. 3A). 
3.3. Sulfoquinovose did not promote intestinal inflammation or growth of 
B. wadsworthia in conventional mice 
To assess the effects of the SQDG metabolite SQ, the latter was orally 
applied to conventional IL-10-/- mice for three weeks. TC was adminis-
tered to a second group of mice as a positive control, whereas water was 
applied as vehicle control to a third mouse group. The applied single TC 
doses correspond to those reported in the previous study (Devkota et al., 
2012), and SQ was used at equimolar doses. No changes in body weight 
Fig. 3. Bacterial abundance in cecal contents of conventional IL-10-/- mice fed control diet (CD) or Spirulina diet (SD). (A) Cell counts of B. wadsworthia determined 
by qPCR (mean ± SEM, ****P < 0.0001, n = 12 per group, note that 5 values had to be excluded in the SD group, as no specific amplification was detectable). (B) 
β-Diversity of microbial profiles as assessed by 16S rRNA gene sequencing (n = 5 per group). 
Fig. 4. Inflammation-associated parameters in conventional IL-10-/- mice gavaged with water, sulfoquinovose (SQ) or taurocholate (TC). (A) Body weight devel-
opment relative to the first day of intervention. Dashed line at 0 % body weight change (mean ± SEM, n = 10 - 12 per group). (B) Consumed diet per mouse and day 
(mean ± SEM, **P < 0.01, n = 10 - 12 per group). (C) Histopathologic scoring of cecal tissue (mean ± SEM, n = 10 – 12 per group). Straight line indicates the 
maximal score of 28. (D) Gene expression analysis of cytokines in cecal mucosa (median + 95 % CI, *P < 0.05, ***P < 0.001, ****P < 0.0001, n = 10 - 12 per group). 
(C) Plasma concentrations of inflammatory markers (mean ± SEM, n = 3 – 4 per group). Ifn-γ, interferon γ; Il, interleukin; LCN 2, lipocalin 2; SAA, serum amyloid A; 
Tnf-α, tumor necrosis factor α; n.d. = not detected. 
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were observed during the intervention for all groups (Fig. 4A). Feed 
consumption was reduced in TC mice compared to SQ- and 
water-treated mice on days seven and 18 by 0.8–1.0 g per mouse on 
average (Fig. 4B). Pathologic changes in cecal tissues of all groups were 
not observed, as assessed by histopathological scoring (Fig. 4C). Gene 
expression of cytokines in cecal mucosa of SQ-treated mice was unaf-
fected. In contrast, expression levels of Ifn-ɣ, Il-6 and Il-1β in cecal mu-
cosa of TC-treated mice were 2.8-fold, 1.8-fold and 4.8-fold, 
respectively, higher relative to water-treated mice (Fig. 4D). Plasma 
concentrations of inflammatory markers of mice gavaged with SQ or TC 
did not differ from those of the control mice (Fig. 4E). 
Fecal cell numbers of B. wadsworthia before SQ or TC application 
were 7.8 ± 0.3 log/g and 7.9 ± 0.4 log/g, respectively, and did not differ 
from controls (Supplementary Fig. 2B). Cecal abundance of 
B. wadsworthia was not affected by SQ application, whereas TC gavage 
led to a 0.3 log/g higher cell number of this bacterium compared to the 
vehicle control (Fig. 5A). Differences in β-diversity of cecal microbiota 
were observed for TC-gavaged but not SQ-treated mice, each compared 
to the control group (Fig. 5B, C). No changes in α-diversity were detected 
(data not shown). The β-diversity of the fecal microbiota of SQ mice did 
not differ from that of control mice at 0 d and 18 d, and no changes were 
observed over 18 d in the SQ mice or the control mice (Supplementary 
Fig. 4). The β-diversity of the fecal microbiota of TC mice differed to 
some extent from that of control mice at both 0 d (P = 0.005) and 18 d (P 
= 0.038) (Supplementary Fig. 5A, B). However, major changes in 
microbiota composition occurred in response to TC treatment as obvious 
from comparing the β-diversity in feces at 0 d and 18 d (P = 0.006) 
(Supplementary Fig. 5C). Application of TC to mice resulted in a 
reduction of the relative abundance of Porphyromonadaceae OTUs as 
observed in feces from 0 d to 18 d (28.2 versus 14.1 %, P = 0.008), while 
OTUs of Desulfovibrionaceae increased during this time period (1.1 versus 
2.5 %, P = 0.008). Desulfovibrionaceae members were also more abun-
dant after 21 d in cecal content of TC-gavaged mice as compared to the 
control group (5.0 versus 2.8 %, P = 0.008). 
3.4. Sulfoquinovose did not elicit an inflammatory response or major 
alterations in gut bacterial composition in SIHUMI mice with or without 
B. wadsworthia 
To investigate the influence of the selected sulfonates on the growth 
of B. wadsworthia in a defined microbial community, gnotobiotic mice 
harboring a simplified human intestinal microbiota in the presence of 
B. wadsworthia (SIHUMI + Bw) or its absence (SIHUMI) were gavaged 
with water, SQ or TC over three weeks. After an initial 2.2–3.2 % drop in 
body weight in the three SIHUMI + Bw groups, mice of all experimental 
groups gained some weight. No statistically significant differences in 
body weight gain and feed consumption were detected among SIHUMI 
or SIHUMI + Bw groups (Supplementary Fig. 6). There were no signs of 
inflammation in the cecum of mice of any of the groups as assessed by 
histopathological scoring (Fig. 6A), colon permeability (Fig. 6B) and 
gene expression of mucosal cytokines (Fig. 6C, D), with exception of the 
TC-gavaged SIHUMI + Bw animals (Fig. 6B, D). The latter showed 
elevated expression levels of Ifn-ɣ (3.5-fold) and Tnf-α (2.1-fold) 
(Fig. 6D) and a slightly increased colonic permeability (Fig. 6B) 
compared to the control mice. Levels of inflammatory markers deter-
mined in plasma were not indicative of a systemic inflammation in SQ- 
Fig. 5. Bacterial abundance in cecal contents of conventional IL-10-/- mice orally treated with water (H2O), sulfoquinovose (SQ) or taurocholate (TC). (A) Abundance 
of B. wadsworthia determined by qPCR (median ± 95 % CI, *P < 0.05, n = 12 per group). β-Diversity of microbial profiles of (B) SQ versus H2O group and (C) TC versus 
H2O group as assessed by 16S rRNA gene sequencing (n = 5 per group). 
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or TC-treated gnotobiotic mice (Fig. 6E, F). 
Fecal cell numbers of B. wadsworthia did not differ among the groups 
at the beginning of the study (Supplementary Fig. 2C). The growth of 
B. wadsworthia in the cecum was stimulated by application of SQ (0.4 
log/g), but not by TC (Fig. 7). The overall composition of the SIHUMI or 
SIHUMI + Bw microbial communities was neither affected by SQ nor TC 
gavage (Supplementary Fig. 7). 
3.5. The cecal expression of Sqr and Hif-1α was not stimulated in 
sulfonate-treated mice 
Degradation of the sulfonates by gut microbiota, as demonstrated for 
SQ and TC in the present study (see above), may result in an increase of 
the intestinal H2S concentration. This may induce the synthesis of host 
enzymes involved in H2S detoxification such as sulfide:quinone oxido-
reductase (SQR). Highly increased concentrations of H2S could impair 
respiration in mitochondria triggering the induction of the hypoxia- 
inducible factor 1α (HIF-1α). To monitor those effects of H2S following 
sulfonate intake in our study, the expression of Sqr and Hif-1α was 
assessed in cecal mucosa of the mice. However, neither Spirulina feeding 
nor oral treatment with SQ or TC induced the expression of Sqr or Hif-1α 
relative to the respective control groups (Supplementary Fig. 8). This 
result was similar for conventional and gnotobiotic mice. 
Fig. 6. Inflammation-associated parameters in gnotobiotic IL-10-/- mice treated with water, sulfoquinovose (SQ) or taurocholate (TC). (A) Histopathologic scoring of 
cecal tissue (mean ± SEM, n = 8 per group). Straight line indicates the maximal score of 28. (B) FITC-dextran concentrations in plasma following the colon 
permeability test conducted after two weeks of intervention (mean ± SEM, *P < 0.05, n = 5 per FITC-dextran group, n = 3 per PBS group). (C) Gene expression 
analysis of cytokines in cecal mucosa of SIHUMI mice and (D) SIHUMI + B. wadsworthia (SIHUMI + Bw) mice (median + 95 % CI, *P < 0.05, n = 8 per group). (E) 
Concentrations of inflammatory markers in plasma samples of SIHUMI mice and (F) SIHUMI + Bw mice (mean ± SEM, n = 3 – 4 per group). Ifn-γ, interferon γ; Il, 
interleukin; LCN 2, lipocalin 2; SAA, serum amyloid A; Tnf-α, tumor necrosis factor α; n.d. = not detected. 
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4. Discussion 
The onset and severity of IBD are, among others, strongly affected by 
the diet and ensuing effects on the intestinal microbiota (Devkota and 
Chang, 2015). Therefore, it is important to identify dietary components 
that contribute to the gut microbiota-mediated promotion of chronic 
intestinal inflammation in humans. Based on a report of detrimental, 
B. wadsworthia-mediated effects of the endogenous sulfonated bile acid 
TC in IL-10-/- mice (Devkota et al., 2012), we studied the 
microbiota-dependent pro-inflammatory potential of the sulfonates 
SQDG enriched in diet and their bacterial metabolite SQ in the identical 
colitis-prone mouse model. 
The intestinal microbiota of the conventional IL-10-/- mice used in 
our study was demonstrated to metabolize both SQ and TC with sub-
sequent formation of H2S. The degradation of SQ to H2S was reported to 
involve at least two bacterial species, the first of which converts SQ to 
DHPS (e.g., E. coli) and the second degrades DHPS to H2S (e.g., 
B. wadsworthia, Desulfovibrio sp. strain DF1) (Burrichter et al., 2018; 
Denger et al., 2014; Liu et al., 2020b). TC can be deconjugated by bile 
salt hydrolase (BSH) present in several gut bacteria (Urdaneta and 
Casadesús, 2017) and the resulting taurine degraded to H2S by 
B. wadsworthia (Laue et al., 1997; Xing et al., 2019). The latter was a 
member of the microbial community in the intestines of our experi-
mental mice. In gnotobiotic IL-10-/- mice harboring the SIHUMI +
B. wadsworthia consortium, SQ is expected to be degraded to H2S by the 
combined action of E. coli and B. wadsworthia strains in agreement with 
previous in vitro studies (Haange et al., 2020). Other members of the 
SIHUMI consortium have not been described to carry genes encoding 
SQ-converting enzymes so far known (Denger et al., 2014; Frommeyer 
et al., 2020). The conversion of DHPS to H2S by B. wadsworthia is 
catalyzed by the DHPS-sulfolyase (HpsG) (Liu et al., 2020b). A 
TC-deconjugating BSH might be active in the Lactobacillus, Bifidobacte-
rium, Bacteroides or Clostridium strains of the SIHUMI consortium 
(Urdaneta and Casadesús, 2017; Dong and Lee, 2018). Further taurine 
degradation is catalyzed by the added B. wadsworthia only, as demon-
strated previously (Haange et al., 2020). 
The results regarding effects of the sulfonates presented here focus 
on the cecum, as the cell density of B. wadsworthia was higher in cecal 
content and the observed effects were stronger than in the colon (data 
not shown). Feeding IL-10-/- mice the diet supplemented with 20 % 
Spirulina led to a consumption of approximately 23 g of this cyano-
bacterium per kg body weight. This corresponds to an estimated daily 
intake of 200 mg SQDG per kg body weight, based on the given lipid 
content of the Spirulina supplement and literature data on the per-
centage of SQDG in the lipid fraction of A. platensis (Xue et al., 2002). 
The consumption of the SQDG-rich Spirulina diet by mice neither 
decreased intestinal permeability nor increased gene expression of 
major pro-inflammatory cytokines in cecal mucosa or the concentration 
of inflammatory markers in plasma. However, expression of Tnf-α in the 
cecal mucosa and the cecal histopathology score were moderately 
increased following Spirulina feeding, but remained overall at a low 
level compared with previous studies (Ganesh et al., 2013; Ring et al., 
2019). Immunomodulatory effects of Spirulina, in particular stimulation 
of cytokine production, have been described previously (Wu et al., 
2016). A moderate increase of TNF-α has been observed in healthy wild 
type mice in response to the administration of a low Spirulina dose (800 
mg/kg body weight) (Shokri et al., 2014). However, most in vitro and in 
vivo studies on inflammation-associated diseases such as colitis or 
arthritis showed a Spirulina-induced reduction of pro-inflammatory 
cytokines (Wu et al., 2016). Consistently, Spirulina has been reported 
to have a wide range of health benefits, including anti-oxidant, hep-
atoprotective and antihyperglycemic effects (Buono et al., 2014) and, 
therefore, is marketed as functional food. Most of these beneficial effects 
have been attributed to its richness in trace elements, minerals, vitamins 
(e.g. carotenoids), pigments (e.g. C-phycocyanin) and essential fatty 
acids (Furmaniak et al., 2017). Moreover, Spirulina has long been 
appreciated as a valuable source of protein with contents of up to 77 % 
of dry weight (Furmaniak et al., 2017). 
In our study, Spirulina-fed mice harbored two orders of magnitude 
lower cecal cell numbers of B. wadsworthia than control mice, which 
corresponds to the lower relative abundance of Desulfovibrionaceae OTUs 
observed in ceal contents. Such a strong depletion of this pathobiont has 
not been described in the literature so far and adds to the reported 
beneficial effects of Spirulina. A general impact of Spirulina feeding on 
β-diversity of gut microbiota as observed in the present study was 
already described for mice previously (Hu et al., 2019; Rasmussen et al., 
2009). However, the observed effects appear to be caused by bioactive 
compounds other than SQDG contained in Spirulina, which is also in line 
with the outcome of the SQ application experiment. 
The impact of the SQDG metabolite SQ on the host and its intestinal 
microbiota composition has not been studied until now. Previous work 
on SQ focused on its conversion to H2S by environmental bacteria and 
the distribution of the involved enzymes in α-, β- and ɣ-proteobacteria 
(Burrichter et al., 2018; Denger et al., 2014). The formation of high 
amounts of H2S from SQ by bacteria in the gut may elicit cytotoxic ef-
fects (see discussion below), leading to intestinal inflammation. How-
ever, SQ did not evoke any inflammatory response when applied at 
doses equimolar to those of TC for three weeks to conventional or 
gnotobiotic IL-10-/- mice in our studies. In line with this, the intestinal 
microbiota profile was not affected by SQ gavage and only a slight in-
crease in B. wadsworthia numbers were observed in gnotobiotic mice. 
The amount of SQ applied daily as pure compound (1.37 mmol/kg body 
weight) was somewhat higher than its estimated intake with the 
Spirulina-supplemented diet (ca. 0.38 mmol/kg body weight). 
The application of TC was included as a positive control in our study, 
as it was previously reported that TC evoked a higher abundance of 
B. wadsworthia and induced severe colitis in conventional and mono- 
associated IL-10-/- mice, characterized by elevated histopathology 
scores and the production of IFN-ɣ in mesenteric lymph nodes (Devkota 
et al., 2012). In the present study, TC application to conventional mice 
stimulated the expression of Ifn-ɣ, Il-6 and Il-1β. In SIHUMI + Bw mice, 
TC induced the expression of Ifn-ɣ and Tnf-α and increased colonic 
permeability. However, the histopathology scores and inflammatory 
markers in plasma were neither elevated in conventional nor in gnoto-
biotic mice. The present results are in conflict with those previously 
published for TC (Devkota et al., 2012). Also, these authors reported a 
2000-fold higher abundance of B. wadsworthia in response to TC treat-
ment (Devkota et al., 2012), whereas in our study the cell number of this 
bacterium was only two-fold higher in cecal contents of TC mice 
compared to control mice harboring a complex microbiota. Possible 
reasons for this discrepancy in conventional mice are differences in the 
animal facility-specific gut microbiota composition of mice, which may 
Fig. 7. Abundance of B. wadsworthia in cecal contents of SIHUMI +B. wadsworthia 
(SIHUMI + Bw) IL-10-/- mice orally treated with water, sulfoquinovose (SQ) or 
taurocholate (TC). Data presented as mean ± SEM (*P < 0.05, n = 8 per group). 
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be crucial for the effects of TC in this mouse model. Environmental 
factors such as feed composition, water treatment or animal handling 
may further affect colitis development, even though the same animal 
model was used (Mähler and Leiter, 2002). 
Bile acids have generally been reported to favor the growth of 
B. wadsworthia and impact the overall gut microbiota composition pro-
foundly (Zheng et al., 2017). The fecal microbiota composition of con-
ventional IL-10-/- mice changed in the course of our experiments in 
response to TC treatment. However, differences in β-diversity between 
TC and control groups were observed in feces and cecal content not only 
at the end of the experiment but in feces unexpectedly also at the 
beginning of the study. A high-fat diet-like phenotype, which is char-
acterized by increased body weight, fat mass and liver weight and can be 
evoked by bile acid supplementation (Zheng et al., 2017) was not 
observed in the present study. The TC dose used in our study (1.86 
mmol/kg body weight) corresponds to the amount of TC excreted daily 
with bile into the intestinal tract of approximately 1.73 mmol/kg body 
weight as estimated according to data from chow-fed C57BL/6 mice of 
the same age (Lickteig et al., 2019). Regarding transferability of results 
from mice to humans, it has to be pointed out that the murine and 
human bile acid composition differs considerably, which also includes 
the ratio of taurine- and glycine-conjugated bile acids (Ridlon et al., 
2016). 
In addition to the experiments with conventional IL-10-/- mice, we 
investigated the influence of sulfonates on the growth of B. wadsworthia 
and ensuing consequences for the host in mice harboring the well- 
defined microbial SIHUMI consortium, as described above. This exper-
imental setup allows to study the behavior and effects of an individual 
bacterium in vivo as part of an intestinal microbiota of reduced 
complexity but avoiding the largely artificial mono-association with this 
species. Colonization of SIHUMI mice with B. wadsworthia had no in-
fluence on their feed consumption or overall body weight gain. Major 
differences in the ratio of SIHUMI consortium members did not occur in 
response to the presence of B. wadsworthia. Even in the SIHUMI + Bw 
control group receiving no TC, colonization of B. wadsworthia was stable. 
Contrary to this, Devkota et al. reported that mono-association of mice 
with B. wadsworthia could only be maintained when TC was gavaged 
simultaneously (Devkota et al., 2012). This discrepancy illustrates how 
model selection may impact the outcome of studies on in vivo effects of 
certain gut bacteria. 
A moderate immune response towards B. wadsworthia was observed 
after TC application with an elevated gene expression of Ifn-ɣ and Tnf-α 
in the cecal mucosa of gnotobiotic mice and an increased colonic 
permeability. However, this B. wadsworthia-dependent inflammatory 
response in the presence of TC was much less severe than described in 
previous studies (Devkota et al., 2012; Feng et al., 2017). A reason for 
this discrepancy may be the application of different B. wadsworthia 
strains in the individual studies. Feng et al. utilized an isolate from a 
human patient suffering from latent autoimmune diabetes in adults and 
Devkota et al. applied strain ATCC 49260T originating from a patient’s 
perforated appendiceal abscess (Devkota et al., 2012; Feng et al., 2017). 
In the present study, B. wadsworthia DSM 11045 was used, a strain iso-
lated from mud of an anaerobic sewage plant indicating a possible 
human fecal source. The B. wadsworthia strains may differ in their col-
itogenic potential as has been described for other gut bacterial species (e. 
g. probiotic E. coli Nissle 1917 versus pathogenic adherent-invasive E. coli 
LF82, Clavel et al., 2017). However, this needs to be clarified in future 
studies. 
Utilization of the applied sulfonates by gut bacteria could have 
caused an increase of the intestinal H2S concentration. The effects of H2S 
in the gut are concentration-dependent and controversially discussed. 
Recent findings indicate that H2S at low physiological concentrations 
(nM) is effectively oxidized by enzymes such as SQR, resulting in an 
increased oxygen consumption and ATP production in mitochondria of 
epithelial cells. Higher levels of H2S (lower μM) induce stronger Sqr 
expression, and oxygen consumption in mitochondria is further 
increased. However, when the H2S concentration exceeds physiological 
levels (middle μM to mM), the mitochondrial cytochrome c oxidase is 
inhibited and the cells enter a hypoxic state. As a consequence, HIF-1α is 
produced together with pro-inflammatory cytokines (Beaumont et al., 
2016; Blachier et al., 2019). In the present study, application of various 
sulfonates did not stimulate the expression of Sqr or Hif-1α in cecal 
mucosa of mice indicating no elevated H2S concentrations and associ-
ated hypoxia or inflammation. 
5. Conclusions 
In recent years, the gut bacterial sulfur metabolism has been dis-
cussed intensively in the context of potential clinically relevant conse-
quences related to chronic intestinal inflammation. Sulfonates that may 
serve as substrates for sulfite-reducing bacteria include taurine- 
conjugated bile acids and dietary plant components. In the present 
study, the pro-inflammatory potential of the dietary sulfolipids SQDG 
and their degradation product SQ were investigated in a murine model 
of chronic colitis harboring a complex or minimal intestinal microbiota. 
The SQDG-rich cyanobacterium Spirulina fed to conventional IL-10-/- 
mice elicited a mild immune response and reduced the abundance of 
sulfite-reducing B. wadsworthia in the cecum. SQ orally applied to con-
ventional IL-10-/- mice had no effects on cecal immune regulation or gut 
microbiota composition. In IL-10-/- mice colonized with the SIHUMI 
consortium and B. wadsworthia, the cell number of B. wadsworthia 
increased slightly following SQ application. Thus, the effects observed 
with Spirulina supplementation are most likely mediated by constituents 
other than SQDG, as its metabolite SQ induced none of these responses. 
Based on our findings, there are no indications that the dietary sulfo-
nates studied cause bacteria-induced intestinal inflammation in sus-
ceptible hosts. 
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